Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 6, 2021; 9(16): 4052-4062
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4052
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4052
Parotid mammary analogue secretory carcinoma: A case report and review of literature
Feng-He Min, Jia Li, Bo-Qiang Tao, Hui-Min Liu, Zhi-Jing Yang, Lu Chang, Ying-Kun Liu, Wei-Wei Liu, Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun 130021, Jilin Province, China
Feng-He Min, Bo-Qiang Tao, Hui-Min Liu, Zhi-Jing Yang, Lu Chang, Yu-Yang Li, Ying-Kun Liu, Wei-Wei Liu, Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Changchun 130021, Jilin Province, China
Yu-Yang Li, Department of Oral Implant, Hospital of Stomatology, Jilin University, Changchun 130021, Jilin Province, China
Yi-Wen Qin, Department of Stomatology, Chongqing Medical University, Chongqing 400016, China
Author contributions: Min FH and Li J contributed equally to this work; Tao BQ, Liu HM, Yang ZJ, Chang L, Li YY, Liu YK, and Qin YW collected and analyzed the data; Min FH and Li J prepared the manuscript; Liu WW, Min FH, and Li J revised and drafted this manuscript; Liu WW provided the funding support in the study; All authors read and approved the final manuscript.
Supported by International Science and Technology Cooperation Project of Jilin Province Science and Technology Department , China, No. 20200801077GH; Science and Technology Project of Jilin Provincial Department of Finance , China, No. JCSZ2019378-8; Jilin Provincial Development and Reform Commission Project , China, No. 2019C051-5.
Informed consent statement: Informed written consent was obtained from the patient to publish this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei-Wei Liu, PhD, Chief Physician, Professor, Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, No. 1500 Qinghua Road, Changchun 130021, Jilin Province, China. liuweiw@jlu.edu.cn
Received: January 18, 2021
Peer-review started: January 18, 2021
First decision: February 11, 2021
Revised: February 17, 2021
Accepted: March 13, 2021
Article in press: March 13, 2021
Published online: June 6, 2021
Peer-review started: January 18, 2021
First decision: February 11, 2021
Revised: February 17, 2021
Accepted: March 13, 2021
Article in press: March 13, 2021
Published online: June 6, 2021
Core Tip
Core Tip: Mammary analogue secretory carcinoma is a rare low-grade malignant salivary gland tumor. The morphological and immunohistochemical features of mammary analogue secretory carcinoma closely resemble those of breast secretory carcinoma. The key characteristics of the lesion are a lack of pain and slow growth. There is no obvious specificity in the clinical manifestations and imaging features. The diagnosis of this disease is particularly difficult. This report describes a rare case of a 32-year-old male patient who presented with a gradually growing lesion that was initially diagnosed as breast-like secretory carcinoma of the right parotid gland. Imaging and histological investigations were used to overcome the diagnostic difficulties.